Advertisement

Therapies for Starting and Stopping Labour

  • Andrew A. Calder
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 7)

Abstract

The clinical objective of exercising control over the human uterus arises when it becomes desirable either to interrupt the pregnancy or to inhibit parturition. The most obvious examples of these requirements are when the appropriate timing of parturition has been disturbed either by failing to occur at term of pregnancy or by commencing or threatening to commence before term. In both of these circumstances, the welfare of the fetus may be in jeopardy and may ultimately depend on the clinician’s ability to cause it to remain within the uterus while it matures or to bring about its safe expulsion from a hostile environment.

Keywords

Uterine Cervix Preterm Labour Labour Induction Cervical Ripening Fetal Hypoxia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akerlund M et al. (1985) The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynaecol Scand 64:499–504CrossRefGoogle Scholar
  2. Akerlund M et al. (1987) Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 94: 1040–1044PubMedCrossRefGoogle Scholar
  3. Barclay CG, Brennand JE, Kelly RW, Calder AA (1993) Interleukin-8 production by the human cervix: Another factor in cervical ripening. Am J Obstet Gynecol 169:625–632PubMedCrossRefGoogle Scholar
  4. Bell WB (1909) The pituitary body and the therapeutic value of infundibular extract in shock, uterine atony and intestinal paresis. BMJ 2:1609–1613PubMedCrossRefGoogle Scholar
  5. Benedetti TJ (1983) Maternal complications of parenteral β sympathomimetic therapy for premature labor. Am J Obstet Gynecol 145: 1PubMedGoogle Scholar
  6. Berg G et al. (1982) β adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after β mimetic treatment. Am J Obstet Gynecol 151: 392–396Google Scholar
  7. Bishop EH (1964) Pelvic scoring for elective induction. Obstet Gynecol 24:266–268PubMedGoogle Scholar
  8. Boissonas RA et al. (1955) A new synthesis of oxytocin. Helvetica Chimica Acta 38:1491–1495CrossRefGoogle Scholar
  9. Bygdeman M, Swahn ML (1985) Progesterone receptor blockade: Effect on uterine contractility in early pregnancy. Contraception 32: 45–51PubMedCrossRefGoogle Scholar
  10. Calder AA (1979) Management of the unripe cervix. In: Anderson ABM, Keirse MJNC (eds) Human parturition: new concepts and developments. Leiden University Press, LeidenGoogle Scholar
  11. Calder AA (1981) The human cervix in pregnancy: a clinical perspective. In: Ellwood DA, Anderson ABM (eds) The Cervix in Pregnancy and Labour. Clinical and Biochemical Investigations, Edinburgh, Churchill Livingstone, pp 103–122Google Scholar
  12. Calder AA (1983) Methods of induction of labour. In: Studd J (ed) Progress in Obstet Gynaecol, Volume 3: Churchill Livingstone, Edinburgh, pp 145–264Google Scholar
  13. Calder AA (1987) Prostaglandins — their role in labour and labour induction. In: Keirse MJNC, de Koning HJ (eds) Priming and induction of labour by prostaglandins. “ A State of the Art”. Leiden, Boerhaave Cursus, pp 79–86Google Scholar
  14. Calder AA, Greer IA (1991) Pharmacological Modulation of Cervical Compliance in the First and Second Trimesters of Pregnancy. Semin Perinatol 15 (2): 162–172PubMedGoogle Scholar
  15. Calder AA, Greer IA (1992a) Prostaglandins and the cervix. Bailliere’s Clinical Obstet Gynaecol 6:771–786CrossRefGoogle Scholar
  16. Calder AA, Greer IA (1992b) Cervical physiology and induction of labour. In: Bonnar J (ed) Recent advances in obstetrics and gynaecology, vol 17. Churchill Livingstone, Edinburgh, pp 33–56Google Scholar
  17. Calder AA, Elder MG (1993) Prostaglandins for cervical ripening and labour induction. In: Vane JR and Grady J (eds) Clinical Application of Prostaglandins. Sevenoaks, Arnold, pp 92–104Google Scholar
  18. Dale HH (1906) On some physiological aspects of ergot. J Physiol 34:163PubMedGoogle Scholar
  19. DuVigneaud V et al. (1953) The sequence of amino acid in oxytocin with a proposal for the structure of oxytocin. J Biol Chem 205:949–955Google Scholar
  20. Frydman R et al. (1991) Mifepristone for induction of labour. Lancet 337:488–489PubMedCrossRefGoogle Scholar
  21. Ghosh A, Hudson FP (1972) Oxytocic agents and neonatal hyperbilirubinaemia. Lancet ii:823CrossRefGoogle Scholar
  22. Gordon AJ, Calder AA (1977) Oestradiol applied locally to ripen the unfavourable cervix. Lancet 2:1319–1321PubMedCrossRefGoogle Scholar
  23. Greer IA, McLaren M, Calder AA (1990) Plasma prostaglandin E2 and prostaglandin F metabolite levels following vaginal administration of prostaglandin E2 for induction of labor. Acta Obstet Gynecol Scand 69:621–625PubMedCrossRefGoogle Scholar
  24. Hisaw FL (1926) Experimental relaxation of the pubic ligament of the guinea pig. Proceedings of the Society of Exploratory Biological Medicine 23:661–663CrossRefGoogle Scholar
  25. Horton EW (1972) Prostaglandins. William Heinemann Medical Books Ltd., London, Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  26. Ito A et al. (1988) Spontaneous production of interleukin-1-like factors from pregnant rabbit uterine cervix. Am J Obstet Gynecol 160:1117–1123Google Scholar
  27. Keirse MJNC (1979) Endogenous prostaglandins in human parturition. In: Keirse MJNC, Anderson A, Bennebroek Gravenhorst J (eds) Human Parturition. Leiden University Press, Leiden, pp 101–142CrossRefGoogle Scholar
  28. Keirse MJNC (1992) Inhibitors of prostaglandin synthesis for treatment of preterm labour. In: JO Drife, AA Calder (eds) Prostaglandins and the Uterus. Springer, London, pp 277–296CrossRefGoogle Scholar
  29. Kelly RW, Buckman A (1990) Antiprogestagenic inhibition of uterine prostaglandin inactivation: a permissive mechanism for uterine stimulation. J Steroid Biochem Mol Biol 37:97–101PubMedCrossRefGoogle Scholar
  30. Kelly RW et al. (1992) Choriodecidual production of interleukin-8 and mechanism of parturition. Lancet 339:776–777PubMedCrossRefGoogle Scholar
  31. Kennedy JH et al. (1982) Induction of labour: a comparison of a single prostaglandin E2 vaginal tablet with amniotomy and intravenous oxytocin. Br J Obstet Gynaecol 89:704–707PubMedCrossRefGoogle Scholar
  32. King JF et al (1988). Betamimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 95:211–222PubMedCrossRefGoogle Scholar
  33. Lyrenas S et al. (1986) Pharmacokinetics of terbutaline during pregnancy. Eur J Clin Pharmacol 29:619–623PubMedCrossRefGoogle Scholar
  34. MacLennan AH et al. (1980) Ripening of the human cervix and induction of labour with purified porcine relaxin. Lancet i:220CrossRefGoogle Scholar
  35. Mochizuki M, Tojo S (1980) Effect of DHA sulphate on softening and dilatation of the uterine cervix in pregnant women. In: Naftolin F, Stubblefield PG (eds) Dilatation of the uterine cervix. New York, Raven Press, pp 267–286Google Scholar
  36. Moise KJ et al. (1988) Indomethacin in the treatment of premature labour: effects on the fetal ductus arteriosus. New Engl J Med 319 (6):327–331PubMedCrossRefGoogle Scholar
  37. Moran-Ellis J (1991) Rupture of the membranes in labour. J Obstet Gynaecol 11(Suppl 1):S6–S10Google Scholar
  38. Novy et al. (1990) Shirodkar cerclage in a multifactorial approach to the patient with advanced cervical changes. Am J Obstet Gynecol 162:1412–1420PubMedCrossRefGoogle Scholar
  39. Pinto RM et al. (1964) Action of oestradiol 17β on the activity of the pregnant human uterus. Am J Obstet Gynecol 88:759–769Google Scholar
  40. Read MD, Wellby DE (1986) The use of calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 93:933–937PubMedCrossRefGoogle Scholar
  41. Rodger MW, Baird DT (1990) Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 97:41–45PubMedCrossRefGoogle Scholar
  42. Romero R et al. (1990) The role of systemic and intrauterine infection in preterm parturition. In: Garfield RE (ed) Uterine Contractility. New York, Raven Press, pp 319–353Google Scholar
  43. Sherwood OD et al. (1990) Relaxin promotes diverse physiological processes in the pregnant rat. In: Garfield RE (ed) Uterine Contractility. New York, Raven Press, pp 237–252Google Scholar
  44. Speert H (1958) Obstetric and Gynecologic Milestones. New York, Macmillan, pp 518–524Google Scholar
  45. Steer CM, Petrie RH (1977) A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 129:1–4PubMedGoogle Scholar
  46. Turnbull AC, Anderson ABM (1968) Induction of labour; results with amniotomy and oxytocin titration. J Obstet Gynaecol of the Br Commonwealth 75:32–41CrossRefGoogle Scholar
  47. Wiqvist N (1979) The use of inhibitors of prostaglandin synthesis in obstetrics. In: Keirse MJNC, Anderson ABM, Bennebroek Gravenhorst J (eds) Human parturition. The Hague, Leiden University Press, pp 189–200CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • Andrew A. Calder

There are no affiliations available

Personalised recommendations